Combidex has a sensitivity of 88% and a specificity of 93% in detecting small lymph node metastases
A negative Combidex MRI precludes in 74% a surgical exploration (e-PLND).
This results in cost-saving of € 1413 per patient and a 19.8%
reduction of surgical conplications.
This video shows how #nano-MRI helped patients, and improved their chance for cure.